Rethinking drug repositioning and development with artificial intelligence, machine learning, and omics M Koromina, MT Pandi, GP Patrinos Omics: a journal of integrative biology 23 (11), 539-548, 2019 | 107 | 2019 |
A novel machine learning-based approach for the computational functional assessment of pharmacogenomic variants MT Pandi, M Koromina, I Tsafaridis, S Patsilinakos, E Christoforou, ... Human Genomics 15, 1-13, 2021 | 23 | 2021 |
The ethnogeographic variability of genetic factors underlying G6PD deficiency M Koromina, MT Pandi, PJ van der Spek, GP Patrinos, VM Lauschke Pharmacological Research 173, 105904, 2021 | 18 | 2021 |
Documentation of clinically relevant genomic biomarker allele frequencies in the next‐generation FINDbase worldwide database F Kounelis, A Kanterakis, A Kanavos, MT Pandi, Z Kordou, O Manusama, ... Human Mutation 41 (6), 1112-1122, 2020 | 8 | 2020 |
Clinical implementation of preemptive pharmacogenomics in psychiatry M Skokou, K Karamperis, MI Koufaki, EE Tsermpini, MT Pandi, ... EBioMedicine 101, 2024 | 7 | 2024 |
Exome-wide analysis of the DiscovEHR cohort reveals novel candidate pharmacogenomic variants for clinical pharmacogenomics MT Pandi, MS Williams, P van der Spek, M Koromina, GP Patrinos Genes 11 (5), 561, 2020 | 6 | 2020 |
A novel text-mining approach for retrieving pharmacogenomics associations from the literature MT Pandi, PJ Van der Spek, M Koromina, GP Patrinos Frontiers in pharmacology 11, 602030, 2020 | 5 | 2020 |
Development of an optimized and generic cost-utility model for analyzing genome-guided treatment data MT Pandi, M Koromina, G Vonitsanos, PJ van der Spek, GP Patrinos, ... Pharmacological Research 178, 106187, 2022 | 2 | 2022 |
Evaluation of crowdsourced mortality prediction models as a framework for assessing artificial intelligence in medicine T Bergquist, T Schaffter, Y Yan, T Yu, J Prosser, J Gao, G Chen, ... Journal of the American Medical Informatics Association 31 (1), 35-44, 2024 | 1 | 2024 |